alopecia (hair loss, balding)
Jump to navigation
Jump to search
Etiology
- generalized hair loss
- telogen effluvium
- anagen effluvium
- alopecia totalis or universalis
- secondary syphilis[9]
- hyperthyroidism
- hypothyroidism
- nutritional deficiencies (protein, iron, zinc, biotin)
- HIV infection
- pharmacologic agents
- localized hair loss
- non-scarring alopecia
- scarring alopecia
- hereditary & developmental
- aplasia cutis congenica
- epidermal nevi
- facial hemiatrophy (Romberg's syndrome)
- infection
- fungal
- microsporum canis
- Microsporum audouinii
- neoplasm
- physical or chemical injury
- lupus erythematosus, discoid lupus (may be non scarring)
- follicular lichen planus (lichen planopilaris)
- sarcoidosis
- morphea
- cicatricial pemphigoid
- acne keloidalis
- folliculitis decalvans
- pseudopalade
- scleroderma
- frontal fibrosing alopecia
- hereditary & developmental
Pathology
- scarring alopecia results in permanent hair loss
- non-scarring alopecia may be reversible[6]
- hair loss in women[4]
- excessive testosterone & dihydrotestosterone
- insufficient estrogen
Genetics
- associated with polymorphism in the androgen receptor
Laboratory
- fungal tests
- hormonal assays
- scalp biopsy, 4 mm punch biopsy[6]
- can distinguish scarring alopecia from non-scarring alopecia[6]
- periphery of lesion best site for biopsy
Diagnostic procedures
Management
- inherited disorders
- some men elect to forgo treatment
- topical minoxidil (Rogaine) BID - best results with patients < 30 with < 5 years hair loss
- surgical procedures
- hair transplant
- scalp reduction
- flaps
- Fungal infections
- oral terbinafine, fluoconazole or itraconazole for ~6 weeks[6]
- oral griseofulvin for ~12 weeks[4]
- 3) ketoconazole is less effective
- topical antifungal agents are generally ineffective
- clean contaminated combs
- evaluate family members
- alopecia areata
- most cases resolve spontaneously
- intralesional or topical glucocorticoids
- systemic glucocorticoids for refractory or extensive disease[6]
- PUVA + prednisolone (recalcitrant alopecia areata)[5]
- 20 mg of methoxsalen, followed 2 hours later by total-body irradiation with ultraviolet A light (UVA) in increasing doses 5 days each week for 4 weeks;
- maximum UVA dose was 80 J/cm2
- oral prednisolone
- hair loss in women[4] {nothing works well}
- minoxidil (Rogaine) only FDA-approved agent
- spironolactone
- finasteride (Propecia)
- flutamide
- Saw palmetto
- oral contraceptives
- estrogen/hormone replacement therapy
- thyroid replacement
- traction alopecia
- decrease tension from hair styling practices
- central centrifugal cicatricial alopecia
- hair straightener or hair relaxer
- topical glucocorticoids, intralesional gluxocorticoids
- frontal fibrosing alopecia
- nutritional interventions with highest-quality evidence for potential benefit:
- Viviscal, Nourkrin, Nutrafol, Lamdapil, Pantogar, capsaicin & isoflavone, omega-3 fatty acids & omega-6 fatty acids with antioxidants, apple nutraceutical, total glucosides of paeony & compound glycyrrhizin tablets, zinc, tocotrienol, & pumpkin seed oil[12]
Comparative biology
- in older mice, dormant stem cells in hair follicles can be activated by Wnt
- in older mice, inhibitors keep the stem cells in a dormant state
- stem cell dormancy can be reversed by the nearby macroenvironment of young skin, that is more stem cells are not needed, but rather a change in the stem cell environment
More general terms
More specific terms
- alopecia areata
- alopecia universalis congenita Mari type
- anagen effluvium
- pattern alopecia
- scarring alopecia; cicatricial alopecia
- telogen effluvium
- traumatic alopecia
- trichorrhexis nodosa
Additional terms
References
- ↑ Harrison's Principles of Internal Medicine, 13th ed. Companion Handbook, Isselbacher et al (eds), McGraw-Hill Inc. NY, 1995, pg 829-39
- ↑ Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 916
- ↑ Harrison's Principles of Internal Medicine, 13th ed. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1994, pg 291-292
- ↑ 4.0 4.1 4.2 4.3 Prescriber's Letter 10(3):17 2003
- ↑ 5.0 5.1 Ito T et al Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata. Arch Dermatol Res 2009 Jun; 301:373. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19301021
- ↑ 6.0 6.1 6.2 6.3 6.4 6.5 Medical Knowledge Self Assessment Program (MKSAP) 16, 17, 18, 19. American College of Physicians, Philadelphia 2012, 2015, 2018, 2022.
- ↑ Mounsey AL, Reed SW. Diagnosing and treating hair loss. Am Fam Physician. 2009 Aug 15;80(4):356-62. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19678603
- ↑ Dahl MV Stemming Hair Loss? NEJM Journal Watch. Aug 13, 2014 Massachusetts Medical Society (subscription needed) http://www.jwatch.org
Chen C-C et al. Regenerative hair waves in aging mice and extra-follicular modulators follistatin, Dkk1, and Sfrp4. J Invest Dermatol 2014 Aug 15; 134:2086. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24618599 <Internet> http://www.nature.com/jid/journal/v134/n8/full/jid2014139a.html
Reddy SK and Garza LA. The thinning top: Why old people have less hair. J Invest Dermatol 2014 Aug 15; 134:2068 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25029319 <Internet> http://www.nature.com/jid/journal/v134/n8/full/jid2014172a.html - ↑ 9.0 9.1 Moshiri AS, Moxam A Syphilitic Alopecia N Engl J Med 2018; 379:1657 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30354954 https://www.nejm.org/doi/full/10.1056/NEJMicm1804118
- ↑ Mubki T, Rudnicka L, Olszewska M, Shapiro J. Evaluation and diagnosis of the hair loss patient: part I. History and clinical examination. J Am Acad Dermatol. 2014 Sep;71(3):415.e1-415.e15. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25128118
Mubki T, Rudnicka L, Olszewska M, Shapiro J. Evaluation and diagnosis of the hair loss patient: part II. Trichoscopic and laboratory evaluations. J Am Acad Dermatol. 2014 Sep;71(3):431.e1-431.e11. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25128119 - ↑ 11.0 11.1 Elston CA, Elston MD Identifying Lesions on Skin of Color. Medscape. 2021. May 10 https://reference.medscape.com/slideshow/identifying-lesions-6007985
- ↑ 12.0 12.1 Drake L, Reyes-Hadsall S, Martinez J et al Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss. A Systematic Review. JAMA Dermatol. Published online November 30, 2022 PMID: https://www.ncbi.nlm.nih.gov/pubmed/36449274 https://jamanetwork.com/journals/jamadermatology/fullarticle/2798840